Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China · Delayed Price · Currency is CNY 20.50
-0.03 (-0.15%)
At close: Feb 27, 2026
SHA:605266 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 127.9 | 128.13 | 414.41 | 374.29 | 300.53 | 251.15 |
Depreciation & Amortization | 822.32 | 822.32 | 748.65 | 609.74 | 481.72 | 25.32 |
Other Amortization | 158.73 | 158.73 | 129.83 | 102.75 | 65.63 | 43.34 |
Loss (Gain) From Sale of Assets | -7.43 | -7.43 | -10.02 | 1.09 | -0.19 | - |
Asset Writedown & Restructuring Costs | 11.18 | 11.18 | 4.93 | 34.93 | - | 0.64 |
Loss (Gain) From Sale of Investments | 9.1 | 9.1 | 7.94 | -0.31 | -5.96 | -0.98 |
Provision & Write-off of Bad Debts | 2.28 | 2.28 | -1.46 | 4.38 | 0.59 | 0.57 |
Other Operating Activities | 492.12 | 171.62 | 148.25 | 103.13 | 65.54 | 19.69 |
Change in Accounts Receivable | -79.02 | -79.02 | 161.57 | -311.86 | -89.8 | -108.89 |
Change in Inventory | -784.21 | -784.21 | -229.67 | -751.97 | -367.59 | -125.17 |
Change in Accounts Payable | 66.39 | 66.39 | -358.87 | 1,048 | 280.98 | 206.81 |
Change in Other Net Operating Assets | 21.79 | 21.79 | 0.65 | 4.51 | 13.96 | - |
Operating Cash Flow | 829.25 | 508.98 | 1,024 | 1,191 | 744.4 | 316.64 |
Operating Cash Flow Growth | 1.43% | -50.31% | -13.96% | 59.94% | 135.10% | -6.21% |
Capital Expenditures | -174.21 | -267.92 | -300.04 | -780.68 | -385.53 | -133.07 |
Sale of Property, Plant & Equipment | 13.34 | 0.11 | 0.31 | 2.4 | 0.02 | 0.04 |
Cash Acquisitions | -0.26 | -464.42 | -129.85 | -1,707 | -321.18 | - |
Investment in Securities | 26.96 | 7.45 | -99.6 | -15.72 | -23.8 | -5 |
Other Investing Activities | 0.49 | 0.34 | 6.65 | 1.86 | 6.32 | 1.04 |
Investing Cash Flow | -133.67 | -724.45 | -522.54 | -2,499 | -724.17 | -136.98 |
Short-Term Debt Issued | - | 1,030 | 427.76 | 29.08 | - | - |
Long-Term Debt Issued | - | 1,471 | 488.05 | 1,540 | 30 | 74 |
Total Debt Issued | 2,304 | 2,501 | 915.82 | 1,569 | 30 | 74 |
Short-Term Debt Repaid | - | -768.39 | -235.93 | - | - | - |
Long-Term Debt Repaid | - | -1,471 | -1,137 | -669.12 | -591.64 | -25.4 |
Total Debt Repaid | -2,649 | -2,240 | -1,373 | -669.12 | -591.64 | -25.4 |
Net Debt Issued (Repaid) | -345.46 | 260.99 | -456.99 | 900.24 | -561.64 | 48.6 |
Issuance of Common Stock | 0 | 43.84 | - | 413.5 | 25.75 | 902.36 |
Repurchase of Common Stock | -54 | -54 | - | - | -0.34 | - |
Common Dividends Paid | -245.17 | -241.86 | -204.92 | -155.04 | -124.03 | -4.48 |
Other Financing Activities | -10.58 | -3.54 | -1.18 | -2.54 | -5.52 | -23.32 |
Financing Cash Flow | -655.21 | 5.43 | -663.09 | 1,156 | -665.78 | 923.16 |
Foreign Exchange Rate Adjustments | -0.84 | -0.24 | - | - | - | -0.01 |
Net Cash Flow | 39.54 | -210.28 | -161.22 | -151.88 | -645.55 | 1,103 |
Free Cash Flow | 655.04 | 241.05 | 724.37 | 409.93 | 358.87 | 183.57 |
Free Cash Flow Growth | 22.53% | -66.72% | 76.71% | 14.23% | 95.50% | -10.18% |
Free Cash Flow Margin | 7.20% | 2.60% | 7.98% | 5.46% | 6.86% | 4.11% |
Free Cash Flow Per Share | 4.25 | 1.56 | 4.68 | 2.70 | 2.57 | 1.60 |
Cash Income Tax Paid | 317.22 | 432.72 | 330.98 | 130.31 | 113.56 | 185.6 |
Levered Free Cash Flow | 387.11 | 136.56 | 545.49 | 164.35 | 406.79 | 208.1 |
Unlevered Free Cash Flow | 464.52 | 221.17 | 621.26 | 226.8 | 437.91 | 210.92 |
Change in Working Capital | -786.95 | -786.95 | -418.12 | -39.39 | -163.46 | -23.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.